Innovassynth Technologies (India) Q1 FY27: Revenue ₹165 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Innovassynth Technologies (India) Ltd Q1 FY27 key numbers
- Revenue
- Revenue from operations for quarter ended 30 June 2026: INR 5,599 Lakhs.
As stated in Innovassynth Technologies (India) Ltd's Q1 FY27 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.
Based on Innovassynth Technologies (India) Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue from operations for quarter ended 30 June 2026: INR 5,599 Lakhs - Revenue from operations for quarter ended 30 June 2025: INR 1,227 Lakhs - Year-on-year revenue growth: Approximately 356% increase (from INR 1,227 Lakhs to INR 5,599 Lakhs) - Quarter ended 30 June 2026: - EBITDA: ₹1,497 lakhs (27% margin) - Operating Expenses: ₹4,102 lakhs (used to calculate margin) - PAT: ₹674 lakhs (12% margin) - Year-on-year comparison (vs Q1
From Innovassynth Technologies (India) Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
2 more points from Innovassynth Technologies (India) Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Innovassynth Technologies (India) Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Life Sciences capacity expansion is underway, aimed at doubling capacity to support growing CRDMO demand (Page 6).
- Capacity expansion is progressing as planned, enabling sustained medium-term growth and profitability improvements (Page 6).
- The company mentions 9 multipurpose manufacturing plants at Khopoli supporting a wide range of chemical processes and production scales (Page 10).
- The order book of INR ~165 crore (Page 7) supports the anticipated growth from the expansion activities.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innovassynth Technologies (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The investor presentation reports an open order book of approximately INR 165 crore as of 30th June 2026 (Page 7).
- It highlights confirmed requirements shared by large global companies, mainly in Life Sciences and Specialty Chemicals (Page 7).
- Major orders are from USA and EU-based companies, with additional orders expected (Page 7).
- The presentation mentions a strong portfolio and custom products supporting the order book (Page 7).
2 more points from Innovassynth Technologies (India) Ltd's call on order book
Create a free account to keep reading this call
Innovassynth Technologies (India) Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Sep 2025 (Q2 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q2 FY26): revenue ₹0 Cr, net loss ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innovassynth Technologies's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Innovassynth Technologies (India) Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Innovassynth Technologies (India) Ltd Q1 FY27 results?
Revenue from operations for quarter ended 30 June 2026: INR 5,599 Lakhs - Revenue from operations for quarter ended 30 June 2025: INR 1,227 Lakhs - Year-on-year revenue growth: Approximately 356% increase (from INR 1,227 Lakhs to INR 5,599 Lakhs) - Quarter ended 30 June 2026: - EBITDA: ₹1,497 lakhs (27% margin) - Operating Expenses: ₹4,102 lakhs (used to calculate margin) - PAT: ₹674 lakhs (12% margin) - Year-on-year comparison (vs Q1
What is Innovassynth Technologies (India) Ltd share price analysis?
Innovassynth Technologies (India) Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,338 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innovassynth Technologies (India) Ltd planning capital expenditure?
Life Sciences capacity expansion is underway, aimed at doubling capacity to support growing CRDMO demand (Page 6).
Keep Innovassynth Technologies (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
